Ardent Health Partners 株価情報 (NYSE: ARDT)

最新ニュース Ardent Health Partners (NYSE:ARDT) 株価情報

Ardent Health Partners

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Ardent Health Partners, Inc. Common Stock

Ardent Health Partners Inc

WIIM

Realty Income shares are trading lower. RBC Capital lowered its price target on the stock from $67 to $63.

Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has risen 12.22% since its last report. The company recently reported that it has 13.72 million shares sold short, which is 13.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.87 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730925023_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Albemarle has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 2.74%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Albemarle's Recent Short Interest

NNN REIT's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) short percent of float has risen 3.45% since its last report. The company recently reported that it has 4.02 million shares sold short, which is 3.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NNN REIT Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730925018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NNN REIT has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NNN REIT's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NNN REIT's peer group average for short interest as a percentage of float is 5.41%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into NNN REIT's Recent Short Interest

West Pharmaceutical Servs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) short percent of float has risen 6.9% since its last report. The company recently reported that it has 1.54 million shares sold short, which is 2.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.42 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>West Pharmaceutical Servs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730925012_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for West Pharmaceutical Servs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing West Pharmaceutical Servs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, West Pharmaceutical Servs's peer group average for short interest as a percentage of float is 5.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into West Pharmaceutical Servs's Recent Short Interest

While Donald Trump has secured a return to the White House, Republicans are still fighting to confirm control of <a href="https://www.benzinga.com/topic/congress">the House of Representatives. </a>
With their newly gained Senate majority, GOP leaders are optimistic about establishing a full governing trifecta that would grant them legislative momentum for the next two years, The Washington Post <a href="https://www.washingtonpost.com/elections/2024/11/06/whats-next-2024-election-swing-states-senate-house-popular-vote/">reports</a>.
What Happened: Republicans are defending their narrow majority in the House, with several critical districts yet to be called. Both parties are closely watching the remaining 20 uncalled districts, which will determine whether Republicans secure unified control in Washington or if Democrats flip the House, challenging the GOP's agenda, <a href="https://www.cnbc.com/2024/11/06/house-control-majority-republicans-red-sweep-democrats.html">according </a>to CNBC.
Here's the list of the 20 uncalled House races at the time of publication Wednesday, <a href="https://www.nbcnews.com/politics/2024-elections/house-results">according</a> to NBC News:
<ol>
<li>Iowa 1 &#8211; GOP: 50.1%, Dem: 49.9% (99% in)</li>
<li>Pennsylvania 10 &#8211; GOP: 50.8%, Dem: 49.2% (99% in)</li>
<li>Nebraska 2 &#8211; GOP: 51.4%, Dem: 48.6% (95% in)</li>
<li>Ohio 9 &#8211; Dem: 48.1%, GOP: 47.8% (94% in)</li>
<li>New York 4 &#8211; Dem: 50.9%, GOP: 49.1% (92% in)</li>
<li>North Carolina 1 &#8211; Dem: 49.4%, GOP: 47.9% (91% in)</li>
<li>Colorado 3 &#8211; GOP: 50.0%, Dem: 46.8% (89% in)</li>
<li>Montana 1 &#8211; GOP: 53.1%, Dem: 43.9% (87% in)</li>
<li>Maine 2 &#8211; Dem: 51.9%, GOP: 48.0% (77% in)</li>
<li>Virginia 7 &#8211; Dem: 51.1%, GOP: 48.9% (76% in)</li>
<li>Colorado 8 &#8211; Dem: 49.5%, GOP: 47.9% (74% in)</li>
<li>Oregon 5 &#8211; Dem: 47.7%, GOP: 45.4% (72% in)</li>
<li>Alaska 1 &#8211; GOP: 49.7%, Dem: 45.3% (71% in)</li>
<li>Washington 3 &#8211; Dem: 52.0%, GOP: 48.0% (70% in)</li>
<li>California 47 &#8211; GOP: 50.6%, Dem: 49.4% (66% in)</li>
<li>California 45 &#8211; GOP: 52.5%, Dem: 47.5% (63% in)</li>
<li>Arizona 6 &#8211; Dem: 49.7%, GOP: 48.2% (59% in)</li>
<li>California 41 &#8211; GOP: 50.5%, Dem: 49.5% (59% in)</li>
<li>California 22 &#8211; GOP: 55.0%, Dem: 45.0% (52% in)</li>
<li>Washington 4 &#8211; GOP: 51.2%, Dem: 48.8% (50% in)</li>
</ol>
Also Read: <a href="https://www.benzinga.com/general/social-media/24/11/41784933/donald-trumps-wealth-soars-with-2024-election-win-heres-how-much-president-elect-is-worth-ho">Donald Trump&#8217;s Wealth Soars With 2024 Election Win: Here&#8217;s How Much President-Elect Is Worth, How Much He&#8217;ll Make In White House</a>
House Speaker Mike Johnson (R-LA) expressed early optimism, saying, "As more results come in, it is clear that, as we have predicted all along, Republicans are poised to have unified government in the White House, Senate, and House." 
Meanwhile, House Minority Leader Hakeem Jeffries (D-NY) said Wednesday that the fight for control of the chamber "remains very much in play," according to The Post.
"In a challenging electoral environment, House Democrats are once again defying political gravity,&#8221; Jeffries said, citing the "enduring strength of our battle-tested incumbents" and other promising signs, such as seat pickups in New York.
Why It Matters: Control of the House will directly impact the next Congress&#8217;s legislative dynamics, particularly with a Trump administration in office. A Republican-controlled House would support Trump&#8217;s agenda with minimal legislative hurdles, while a Democratic win could introduce checks on his administration's policies. 
Key upcoming battles in Congress include government funding measures, which expire in December, and debates on tax policies, with Trump's team aiming to make the 2017 tax cuts permanent.
Republicans currently hold 220 seats in the House, while Democrats have 212 seats, along with three vacancies. The tight race underscores the significance of each uncalled district as the GOP and Democratic Party brace for potential recounts and legal challenges. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">How Did S&amp;P 500 Sectors Perform During Trump&#8217;s First Term? Could This Time Be Different?</a></li>
</ul>
Photo: Shutterstock

News

Politics

House Control Uncertain As Trump Secures White House Return

Chinese artificial intelligence (AI) companies, including tech giants Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) and ByteDance, are investing heavily in advertising to gain a foothold in the competitive AI market.
In the third quarter alone, these companies spent over 500 million yuan ($70.2 million) on promotional campaigns for various AI applications, SCMP <a target="_blank" href="https://www.scmp.com/tech/big-tech/article/3285132/chinese-ai-firms-are-splurging-ads-report-finds-chatbot-market-gets-crowded" rel="noreferrer noopener">reports</a>.
Among the big spenders, Alibaba allocated nearly 200 million yuan to promote Quark, a cloud storage and online search platform enhanced with generative AI features.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41755579/fidelity-national-information-services-banking-capital-markets-growth-drive-optimis" rel="noreferrer noopener">Fidelity National Information Services' Banking, Capital Markets Growth Drive Optimism, Analysts Say</a>
Spending on its ChatGPT-like service, Tongyi Qianwen, was notably lower at 4.5 million yuan. A Tongyi Qianwen spokesperson disputed this figure, SCMP says.
The significant marketing budgets have sparked concerns within China about the sustainability of such high spending.
Chinese AI startup Moonshot AI, backed by Alibaba and Tencent Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>), is among the top ad spenders, with approximately 150 million yuan devoted to promoting its chatbot.
The company's substantial ad budget reflects the increasingly crowded AI market, where hundreds of chatbots are vying for user attention. However, a source close to Moonshot told the SCMP that AppGrowing's data on the company's ad spending is exaggerated.
Yan Junjie, CEO of Shanghai-based AI firm MiniMax, highlighted a fundamental difference in strategy between Chinese and U.S. AI companies.
While American companies rely on product capabilities to attract users, Chinese companies heavily invest in online marketing to differentiate their offerings.
Chinese tech giants Alibaba, Tencent, and Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) spent $7 billion on AI-focused infrastructure and processors in the first half of this year, a significant rise from last year.
Despite increased spending, China's AI capital investments lag behind U.S. firms like Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), which <a target="_blank" href="https://www.benzinga.com/news/24/08/40550305/nvidia-tech-fuels-chinese-ai-growth-overseas-alibaba-ramps-up-7b-investment" rel="noreferrer noopener">spent $106 billion</a>. Wedbush analyst Dan Ives <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41151741/nvidias-ai-leadership-to-drive-1-trillion-market-growth-with-accenture-partnership-" rel="noreferrer noopener">projected $1 trillion</a> in AI capital spending by U.S. tech giants, with Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) a key beneficiary.
Price Action: BABA stock traded lower by 2.93% at $96.31 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com//node/41773691" target="_blank" rel="noreferrer noopener">US-Listed Chinese Stocks Like Alibaba, JD, Nio Fall After Trump's Win &#8211; What's Going On?</a></li>
</ul>
Photo courtesy: Shutterstock

Emerging Markets

Tech

Media

AMZN

BABA

BIDU

GOOG

GOOGL

MSFT

NVDA

TCEHY

Alibaba's AI Strategy: Massive Ad Spend to Dominate Crowded Market

Longer-dated U.S. Treasury bonds, tracked by the popular iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>), saw their steepest decline in over a year on Wednesday, plummeting more than 2.6%, as investors offloaded fixed-income assets amid rising expectations of wider budget deficits and higher inflation, spurred by Donald Trump&#8216;s victory <a href="https://www.benzinga.com/topic/donald-trump">in the presidential election. </a>
This bond sell-off comes one day before a pivotal Federal Reserve interest rate decision scheduled for 2 p.m. ET Thursday.
The Federal Reserve is broadly expected to cut interest rates by 25 basis points to a range of 4.5%–4.75%, a move fully priced in by market participants, according to the CME FedWatch Tool.
While the rate decision itself is almost certain, investors will be more focused on Fed Chair Jerome Powell's remarks, which may offer crucial insights into the Fed&#8217;s stance on the evolving inflation and fiscal policy.
Fed watchers are keen to highlight if a potential shift in fiscal policy under Trump could prompt the Fed to modify its approach.
Economists broadly agree that tariffs and tax cuts are likely to drive up inflation, potentially leading to a more hawkish response from the Federal Reserve. JPMorgan analysts estimate that universal tariffs, coupled with domestic tax cuts, could increase U.S. inflation by as much as 2.4%. 
Goldman Sachs chief economist Jan Hatzius suggests that Trump's policies might keep core inflation above 3% by 2025, well above the Fed's 2% target. Hatzius highlighted that these factors &#8220;might delay cuts that would otherwise come more swiftly.&#8221;
Read also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">Trump&#8217;s Historic Return: 7 Ways His Second Term Could Impact The US Economy</a>
<h3 class="wp-block-heading">Fed Expected To Cut Rates In November, But All Eyes Are On What Comes Next</h3>
"We expect a 25-basis-point cut in November, with Powell likely to maintain an optimistic tone," said Bank of America rates analyst Mark Cabana. He explained that softer-than-expected jobs data for October, combined with downward payroll revisions, were key factors solidifying the case for this November rate cut.
Bank of America also indicated that these labor data trends increase the likelihood of another rate cut in December.
Goldman Sachs economist David Mericle highlighted that recent inflation data has eased concerns about inflation reaccelerating. &#8220;Better inflation news has alleviated fears of sticky inflation from earlier in the year,&#8221; he said. He also emphasized strong Q3 GDP growth as a sign of resilience in the U.S. economy, despite a cooling labor market.
Goldman Sachs now forecasts four additional cuts in the first half of next year, bringing rates down to 3.25%–3.5%.
Mericle acknowledged "uncertainty about both the pace and final rate" of future cuts, noting that the Fed&#8217;s path forward will depend heavily on evolving economic data.
<h3 class="wp-block-heading">Will Trump Pressure Powell on Interest Rates?</h3>
During Thursday&#8217;s Q&amp;A, Powell will likely face questions on whether the Fed plans to act preemptively or reactively in response to changing fiscal dynamics.
Investors are eager to understand if the Fed will proactively address anticipated inflation or wait for economic data to reflect any significant change.
Powell, whose term expires in 2026, could also be questioned about the Fed's independence. In his previous term, Trump frequently pressured the Fed to lower rates and has hinted that, if re-elected, he would not renew Powell's term. 
During Trump's first presidency, he issued over hundreds of tweets criticizing Fed policy, often urging for lower rates, according to data shared by the Brookings Institution. 
<h3 class="wp-block-heading">How Could Markets React To November Fed Meeting?</h3>
Market data suggest a 70% probability of another 25-basis-point cut at the Fed's Dec. 18 meeting, down slightly from 77% the previous day.
If Powell delivers dovish remarks that reinforce expectations of a December rate cut, risk assets could rally. The S&amp;P 500, represented by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), might respond positively, while small-cap stocks, tracked by the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), may extend gains following Wednesday's rally.
Conversely, if Powell signals hesitation about further rate cuts, particularly in December, and indicates a potential inclination toward addressing rising inflation expectations, investors could be disappointed, potentially putting downward pressure on the markets.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">How Did S&amp;P 500 Sectors Perform During Trump&#8217;s First Term? Could This Time Be Different?</a></li>
</ul>
Image: Shutterstock

Equities

Bonds

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Markets

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

US Treasuries Take Sharpest Plunge In A Year Ahead Of Fed Meeting: Could Powell Adjust Stance In Response To Trump?

IRSA Inversiones y (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) reported quarterly losses of $(0.15) per share. This is a 104.61 percent decrease over earnings of $3.36 per share from the same period last year. The company reported $95.62 million in sales this quarter. This is a 4.36 percent decrease over sales of $99.98 million the same period last year.

Earnings

IRSA Inversiones y Q1 EPS $(0.15) Down From $3.36 YoY, Sales $95.62M Down From $99.98M YoY

AAON

ALGT

ALTG

AREB

BECN

CSTE

CSWI

FAST

FERG

FTAI

GATX

HUBG

IIIN

JELD

KTOS

MATW

REZI

ROCK

RUSHA

RUSHB

SKYW

TFII

UFPI

WLFC

Shares of companies within the broader industrial sector are trading higher after Donald Trump won the 2024 presidential election.

$68,000 has been identified as a critical support level for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), following its surge to a new all-time high <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41775353/bitcoin-hits-new-all-time-high-as-donald-trump-wins-second-term-what-now">on election night</a>.
What Happened: In a comprehensive breakdown of Bitcoin&#8217;s performance over the past seven months, crypto trader Scient identified two similar structures within this period: a bearish and a bullish structure.
He <a href="https://x.com/Crypto_Scient/status/1854099370624397670">noted</a> that the first, bearish range formed a high at $73,800 and lows at $59,000. After sweeping the lows at $59,000, it failed to reclaim the demand at this level, resulting in a breakdown and formation of a new low at $53,300.
The second range, bullish in nature, had highs at $70,000 and lows at $53,300. Respecting these lows, it swept the $53,300 lows, followed by a successful retest of the $53,300 lows to confirm the support. This resulted in a bounce and reclaiming of the demand at lows, confirming the strength of the market.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41778425/bitcoins-all-time-high-a-groundbreaking-milestone-and-strong-post-election-rally-coming-ex">Bitcoin&#8217;s All-Time High: &#8216;A Groundbreaking Milestone&#8217; And &#8216;Strong Post-Election Rally&#8217; Coming, Experts Predict</a>
Scient asserts that Bitcoin's current one-day chart remains robust, with $68,000 acting as a crucial support. However, he warns that a break below this could lead to renewed market uncertainty.  
Echoing Scient's analysis, crypto trader Pentoshi expressed confidence in Bitcoin&#8217;s momentum, anticipating a rally beyond $100,000 in the coming months:
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hard to imagine a world where <a href="https://twitter.com/search?q=%24btc&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$btc</a> doesn't trade above $100k in the next several months But I'm guessing most people want to see an update on the alt market overall so I'll do that today. There's a lot to like
&mdash; &#x1f427; Pentoshi (@Pentosh1) <a href="https://twitter.com/Pentosh1/status/1854179291048943727?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41775353/bitcoin-hits-new-all-time-high-as-donald-trump-wins-second-term-what-now">Bitcoin Hits New All-Time High As Donald Trump Wins Second Term: What Now?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

What Do Technical Analysts Say About Bitcoin After The Election? Failing To Hit $100,000 In The Next Months Is 'Hard To Imagine'

IESC

MTRX

MYRG

ROAD

STRL

Shares of construction and engineering companies are trading higher after Donald Trump won the 2024 presidential election.

<a href="https://www.politico.com/news/2024/11/06/biden-trump-ukraine-assistance-00187897">https://www.politico.com/news/2024/11/06/biden-trump-ukraine-assistance-00187897</a>
The Biden administration is planning to rush the last of over $6 billion remaining in Ukraine security assistance out the door by Inauguration Day, as the outgoing team prepares for the weapons flow to end once President-elect Donald Trump takes office.
The plan, described by two administration officials who were granted anonymity to discuss internal matters, is the only option the White House has to keep sending equipment to Ukraine to fight off continued Russian offensives. But the problems are immense. It normally takes months for munitions and equipment to get to Ukraine after an aid package is announced, so anything rolled out in the coming weeks would likely not fully arrive until well into the Trump administration, and the next commander in chief could halt the shipments before they're on the ground.
One big holdup to pushing that aid out the door quickly is that the U.S. can only send equipment already on its shelves. While the money allocated reimburses the Pentagon for that equipment, it is dependent on how fast new artillery shells and weapons can be produced or contracted to replace them.
&nbsp;

Macro Economic Events

Global

'The Biden Administration Is Planning To Rush The Last Of Over $6 Billion Remaining In Ukraine Security Assistance Out The Door By Inauguration Day' - Politico

ACVA

CECO

CPRT

CTAS

CWST

DRVN

NVRI

VIRC

VSEC

Shares of commercial services and supplies companies are trading higher after Donald Trump won the 2024 presidential election.

Lancaster Colony Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) announced today that its Board of Directors has declared a quarterly cash dividend of 95 cents per common share, marking 62 consecutive years of increasing regular cash dividends. The company is one of only 12 U.S. companies with 62 straight years of regular cash dividend increases. The dividend will be payable December 31, 2024 to shareholders of record on December 5, 2024. As of the record date for today's annual shareholder meeting, there were 27,566,647 common shares outstanding.

Dividends

LANC

Lancaster Colony Increases Regular Cash Dividend From $0.90 To $0.95 Per Share

ALNT

ATKR

CETY

HUBB

PLPC

POWL

VICR

Shares of electrical equipment companies are trading higher after Donald Trump won the 2024 presidential election.

ATRO

AXON

EVEX

RKLB

SARO

Shares of aerospace and defense companies are trading higher after Donald Trump won the 2024 presidential election.

Montrose Environmental Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $45.0, a high estimate of $54.00, and a low estimate of $29.00. This current average has decreased by 15.62% from the previous average price target of $53.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1730923259_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Montrose Environmental Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$54.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$54.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Durgesh Chopra</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$43.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Montrose Environmental Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Montrose Environmental Gr compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Montrose Environmental Gr's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MEG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Montrose Environmental Gr analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Montrose Environmental Gr</h2>
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.
<h3>A Deep Dive into Montrose Environmental Gr's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Montrose Environmental Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.94% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -7.45%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Montrose Environmental Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.34%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Montrose Environmental Gr's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.39%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Montrose Environmental Gr's debt-to-equity ratio is below the industry average. With a ratio of 0.59, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: Montrose Environmental Gr In The Eyes Of 4 Experts

In the latest quarter, 7 analysts provided ratings for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Novo Nordisk, revealing an average target of $159.43, a high estimate of $160.00, and a low estimate of $156.00. A decline of 0.36% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1730923248_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Novo Nordisk by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Evan David Seigerman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$156.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Novo Nordisk. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Novo Nordisk compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Novo Nordisk's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Novo Nordisk's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NVO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Novo Nordisk analyst ratings.</a>
<h2>All You Need to Know About Novo Nordisk</h2>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
<h3>Novo Nordisk's Economic Impact: An Analysis</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, Novo Nordisk showcased positive performance, achieving a revenue growth rate of 25.34% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Novo Nordisk's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 29.46%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Novo Nordisk's ROE stands out, surpassing industry averages. With an impressive ROE of 18.97%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Novo Nordisk's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.0% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Novo Nordisk's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.51.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 7 Analyst Projections For Novo Nordisk

Ratings for Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) were provided by 40 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">13</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $203.55, a high estimate of $225.00, and a low estimate of $170.00. Marking an increase of 0.64%, the current average surpasses the previous average price target of $202.26. 
<img src="https://www.benzinga.com/files/images/story/2024/1730923237_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Alphabet among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alan Gould</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$185.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Michael Levine</td>
<td>Pivotal Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Mark Shmulik</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$185.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Rohit Kulkarni</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$212.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Justin Patterson</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$210.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$210.00</td>
<td>$204.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$187.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$217.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$215.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$182.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Ivan Feinseth</td>
<td>Tigress Financial</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$220.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$196.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$222.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$170.00</td>
<td>-</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Neutral</td>
<td>$190.00</td>
<td>-</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Rohit Kulkarni</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$206.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alphabet. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alphabet compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Alphabet's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Alphabet's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alphabet analyst ratings.</a>
<h2>All You Need to Know About Alphabet</h2>
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.
<h3>Understanding the Numbers: Alphabet's Finances</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Alphabet's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 15.09%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Communication Services sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Alphabet's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 29.8% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Alphabet's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.55% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Alphabet's ROA excels beyond industry benchmarks, reaching 6.22%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.09.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 40 Analyst Recommendations For Alphabet

Carpenter Tech's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) short percent of float has risen 5.82% since its last report. The company recently reported that it has 1.70 million shares sold short, which is 4.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.66 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Carpenter Tech Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730923232_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Carpenter Tech has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Carpenter Tech's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Carpenter Tech's peer group average for short interest as a percentage of float is 4.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(CRS) - Analyzing Carpenter Tech's Short Interest

Mizuho Securities analyst Ann Hynes has reiterated their bullish stance on ARDT stock, giving a Buy rating yesterday. Ann Hynes has given her Buy r...

Buy Rating Affirmed: Ardent Health Partners' Impressive Performance and Growth Potential

In a report released yesterday, David S Macdonald from Truist Financial maintained a Buy rating on Ardent Health Partners, Inc. (ARDT – Research Re...

Truist Financial Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ardent Health Partners, Inc. (ARDT – Research Repo...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Buy rating on Ardent Health Partners, Inc. (ARDT – Research Report), ...

Growth and Margin Expansion Opportunities Position Ardent Health for Buy Rating

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Ardent Health Partners, Inc. (ARDT – Research Report), with...

RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)

KeyBanc sees hospitals beating/raising with Q3 earnings

The Momentum Weekly - Are We Ready To Start Trending?

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Five Below downgraded, Snowflake upgraded: Wall Street's top analyst calls

BofA upgraded Humana (HUM) to Neutral, while downgrading three other names in the healthcare space following Donald Trump's election win last night...

BofA shakes up ratings of healthcare stocks following Trump win

Hospital stocks could see negative impact under Trump

ACHC

ADUS

AHCO

ARDT

CORZ

FIVE

MASI

OSCR

PACS

PODD

PRVA

RMBS

RMSYF

SMCI

SNOW

TNDM

Press Releases

Ardent Health Announces Closing of Its Initial Public Offering

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

Ardent Health Reports Second Quarter 2024 Results

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Ardent Health Appoints Dave Styblo to Lead Investor Relations

Ardent Health Completes Term Loan Repricing

Ardent Health Added to Russell 2000® and 3000® Indexes

Ardent Health Partners With Qventus to Drive Strategic Perioperative Growth

Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date

Comments

Ardent Health Partners

ニュース

最新ニュース Ardent Health Partners (NYSE:ARDT) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル